olaparib,abiraterone
astrazeneca,merck
['propel', 'merck', '$mrk', 'astrazeneca', '$azn']
#merck and #astrazeneca present final results of key secondary overall survival endpoint from phase 3 #propel trial at #ascogu23 $mrk $azn 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.